Shaers of Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) have been recommended as a long term growth pick. With the firm’s stock price currently trading around $47.74, the firm has proven a solid track record of growth over the recent years. Investors might consider the stock as a long term growth candidate as the firm has yielded 18.20% earnings per share growth over the past 5 years and 7.30% revenue growth over that same time frame.
Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time. A “buy-and-hold” investor will consider long-term growth as a longer time period then a day trader will. The buy-and-hold strategy looks ahead farther into the future, giving short-term price swings less consideration as long as the fundamentals stay the same.
Let’s take a look at how the stock has been performing recently. Over the past twelve months, Fresenius Medical Care AG & Co. KGAA (NYSE:FMS)’s stock was 13.10%. Over the last week of the month, it was -3.98%, -2.07% over the last quarter, and 14.37% for the past six months.
Over the past 50 days, Fresenius Medical Care AG & Co. KGAA’s stock is -4.77% off of the high and 6.37% removed from the low. Their 52-Week High and Low are as follows: -4.94% (High), 25.47%, (Low).
Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $51.50 on the equity. Analysts have a consensus recommendation of 1.80 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.